Gut Microbiota: A Modulator and Therapeutic Target for Chronic Pain
- PMID: 39652283
- DOI: 10.1007/s12035-024-04663-x
Gut Microbiota: A Modulator and Therapeutic Target for Chronic Pain
Abstract
Chronic pain is a prevalent condition, impacting nearly one-fifth of the global population. Despite the availability of various clinical treatments, each comes with inherent limitations, and few offer a complete cure, resulting in a significant social and economic burden. Therefore, it is important to determine the pathogenesis and causes of chronic pain. Numerous studies have shown a close link between the intestinal microflora and chronic pain. The gut microbiota can exert their effects on chronic pain through both central and peripheral mechanisms and is able to communicate with the brain through its own components or metabolites. They also can regulate chronic pain by affecting pro- and anti-inflammatory cells. This review is aimed at reviewing the connection between gut flora and different types of chronic pain, including visceral pain, neuropathic pain, inflammatory pain, musculoskeletal pain, migraine, and chronic cancer pain; exploring the central and peripheral mechanisms of the influence of gut flora on chronic pain; and attempting to provide novel treatment options for chronic pain, that is, the gut microbiota can be regulated by probiotics, fecal microbial transplantation, and natural products to treat chronic pain. By examining the intricate relationship between gut flora and chronic pain, the review sought to pave the way for new treatment strategies that target the gut microbiota, offering hope for more effective pain management.
Keywords: Central mechanisms; Chronic pain; Intestinal microbiota; Peripheral mechanisms; Therapy.
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Conflict of interest statement
Declarations. Conflict of Interest: The authors declare no competing interests.
Similar articles
-
Gut microbiota in chronic pain: Novel insights into mechanisms and promising therapeutic strategies.Int Immunopharmacol. 2023 Feb;115:109685. doi: 10.1016/j.intimp.2023.109685. Epub 2023 Jan 24. Int Immunopharmacol. 2023. PMID: 37278059 Review.
-
Pain regulation by gut microbiota: molecular mechanisms and therapeutic potential.Br J Anaesth. 2019 Nov;123(5):637-654. doi: 10.1016/j.bja.2019.07.026. Epub 2019 Sep 21. Br J Anaesth. 2019. PMID: 31551115 Review.
-
The Role of the Human Microbiome in the Pathogenesis of Pain.Int J Mol Sci. 2022 Oct 31;23(21):13267. doi: 10.3390/ijms232113267. Int J Mol Sci. 2022. PMID: 36362056 Free PMC article. Review.
-
Unraveling mechanistic insights into the role of microbiome in neurogenic hypertension: A comprehensive review.Pathol Res Pract. 2023 Sep;249:154740. doi: 10.1016/j.prp.2023.154740. Epub 2023 Aug 6. Pathol Res Pract. 2023. PMID: 37567034 Review.
-
Gut microbiota in the pathogenesis of inflammatory bowel disease.Clin J Gastroenterol. 2018 Feb;11(1):1-10. doi: 10.1007/s12328-017-0813-5. Epub 2017 Dec 29. Clin J Gastroenterol. 2018. PMID: 29285689 Review.
Cited by
-
Emerging role of macrophages in neuropathic pain.J Orthop Translat. 2025 Mar 18;51:227-241. doi: 10.1016/j.jot.2025.01.016. eCollection 2025 Mar. J Orthop Translat. 2025. PMID: 40177638 Free PMC article. Review.
-
Neuromodulation in Chronic Migraine: Evidence and Recommendations from the GRADE Framework.Adv Ther. 2025 Jul;42(7):3020-3044. doi: 10.1007/s12325-025-03206-7. Epub 2025 May 8. Adv Ther. 2025. PMID: 40338487 Free PMC article. Review.
References
-
- Dinakar P, Stillman AM (2016) Pathogenesis of pain. In: Seminars in Pediatric neurology. Elsevier, pp. 201–208
-
- Rikard SM (2023) Chronic pain among adults—United States, 2019–2021. MMWR. Morb Mortal Wkly Rep:72
-
- Ashburn MA, Staats PS (1999) Management of chronic pain. Lancet 353(9167):1865–1869 - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical